Cargando…

Anatomical and Functional Outcomes after Endoresection and Adjuvant Ruthenium Brachytherapy for Uveal Melanoma: A Single-Center Experience

Purpose: To evaluate the anatomical and functional outcomes of endoresection and adjuvant ruthenium (Ru)-106 brachytherapy for uveal melanoma (UM). Methods: Retrospective case series of 15 UM patients (15 eyes) treated at our center (Careggi University Hospital, Florence). Results: Six patients (40%...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mazzini, Cinzia, Vicini, Giulio, Di Leo, Laura, Massi, Daniela, Rizzo, Stanislao, Giansanti, Fabrizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146230/ https://www.ncbi.nlm.nih.gov/pubmed/37109431 http://dx.doi.org/10.3390/life13040902

Ejemplares similares

Exoresection and Endoresection for Uveal Melanoma
por: Gündüz, Kaan, et al.
Publicado: (2010)

Brachytherapy of Uveal Melanomas with Ruthenium-106 Plaques
por: Belaïd, Asma, et al.
Publicado: (2016)

Ruthenium brachytherapy for uveal melanoma – single institution experience
por: Rospond-Kubiak, Iwona, et al.
Publicado: (2017)

Long-Term Outcomes in Uveal Melanoma After Ruthenium-106 Brachytherapy
por: Cennamo, Gilda, et al.
Publicado: (2022)

(106)Ruthenium eye plaque brachytherapy in the management of medium sized uveal melanoma
por: Jiang, Ping, et al.
Publicado: (2020)

Outcomes of primary endoresection for choroidal melanoma
por: Vidoris, Andre A. C., et al.
Publicado: (2017)

Vortex vein cauterization and truncation to avoid perfluorocarbon syndrome during endoresection of uveal melanomas: a retrospective study
por: Fiorentzis, Miltiadis, et al.
Publicado: (2022)

Safe endoresection
por: Seider, Michael I, et al.
Publicado: (2014)

Nomogram for predicting radiation maculopathy in patients treated with Ruthenium-106 plaque brachytherapy for uveal melanoma
por: Tagliaferri, Luca, et al.
Publicado: (2017)

Efficacy and complications of ruthenium-106 brachytherapy for uveal melanoma: a systematic review and meta-analysis
por: Karimi, Saeed, et al.
Publicado: (2021)

Ruthenium brachytherapy for iris melanoma
por: Zwolin´ska, Emilia, et al.
Publicado: (2023)

Circulating Tumor Cells Detection and Counting in Uveal Melanomas by a Filtration-Based Method
por: Mazzini, Cinzia, et al.
Publicado: (2014)

Ruthenium-106 brachytherapy for thick uveal melanoma: reappraisal of apex and base dose radiation and dose rate
por: Naseripour, Masood, et al.
Publicado: (2016)

Tumor parameters predict the risk of side effects after ruthenium-106 plaque brachytherapy of uveal melanomas
por: Tarmann, Lisa, et al.
Publicado: (2017)

Respond to: Safe endoresection
por: Modarres, Mehdi, et al.
Publicado: (2015)

Short-term perfluorocarbon liquid tamponade in choroidal melanoma endoresection
por: Hamza, Hany S., et al.
Publicado: (2022)

Ruthenium-106 plaque radiotherapy for uveal melanoma: analysis of tumor dimension and location on anatomical and functional results
por: Mirshahi, Reza, et al.
Publicado: (2022)

Localized Choroidal Melanoma Managed by Pars Plana Endoresection, Endodiathermy, and Endolaser
por: Naser, Ahmed J, et al.
Publicado: (2021)

Recurrence and massive extraocular extension of choroidal malignant melanoma after vitrectomy and endoresection
por: Modarres, Mehdi, et al.
Publicado: (2014)

Optical Coherence Tomography Angiography for the Evaluation of Retinal and Choroidal Vasculature in Retinitis Pigmentosa: A Monocentric Experience
por: Giansanti, Fabrizio, et al.
Publicado: (2022)

Non-Invasive Retinal Imaging Modalities for the Identification of Prognostic Factors in Vitreoretinal Surgery for Full-Thickness Macular Holes
por: Nicolosi, Cristina, et al.
Publicado: (2023)

Forty-year prognosis after plaque brachytherapy of uveal melanoma
por: Stålhammar, Gustav
Publicado: (2020)

Clinical procedure for intraocular electrochemical lysis during endoresection
por: Belyy, YA, et al.
Publicado: (2013)

Adjuvant Ipilimumab in High-Risk Uveal Melanoma
por: Fountain, Eric, et al.
Publicado: (2019)

Brachytherapy for patients with uveal melanoma: historical perspectives and future treatment directions
por: Brewington, Beatrice Y, et al.
Publicado: (2018)

Regression patterns of uveal melanoma after iodine-125 plaque brachytherapy
por: Fang, Rui, et al.
Publicado: (2021)

Clinical Outcomes after Surgical Resection Combined with Brachytherapy for Uveal Melanomas
por: Relimpio-López, Isabel, et al.
Publicado: (2022)

Comparison of Iodide-125 and Ruthenium-106 Brachytherapy in the Treatment of Choroidal Melanomas
por: Ghassemi, Fariba, et al.
Publicado: (2020)

Silicone Oil and Iodine-125 Brachytherapy for Uveal Melanoma in High-Risk Patients
por: Lyons, Lance J, et al.
Publicado: (2019)

Staged Eye-Plaque Brachytherapy: A Novel Approach for Large Uveal Melanoma
por: Chevli, Neil, et al.
Publicado: (2021)

Visual outcome after posterior uveal melanoma episcleral brachytherapy including radiobiological doses
por: Miguel, David, et al.
Publicado: (2018)

Paired comparisons of mutational profiles before and after brachytherapy in asian uveal melanoma patients
por: Lee, Woo Seung, et al.
Publicado: (2021)

Intra-operative ocular ultrasonography of iodine-125 brachytherapy plaques in patients with uveal melanoma
por: Ces, Antonio Piñeiro, et al.
Publicado: (2021)

Prognosis Prediction of Uveal Melanoma After Plaque Brachytherapy Based on Ultrasound With Machine Learning
por: Luo, Jingting, et al.
Publicado: (2022)

A Prognostic Score for the Prediction of Local Treatment Failure in Plaque Brachytherapy of Uveal Melanoma
por: Kal Omar, Ruba, et al.
Publicado: (2022)

MR-based follow-up after brachytherapy and proton beam therapy in uveal melanoma
por: Tang, Michael C. Y., et al.
Publicado: (2023)

Optical Coherence Tomography Angiography for the Evaluation of Retinal Vasculature in Fabry Disease: Our Experience and Review of Current Knowledge
por: Bacherini, Daniela, et al.
Publicado: (2021)

Effectiveness of intravitreal chemotherapy-assisted endoresection in monocular patients with group D retinoblastoma
por: Yu, Xiling, et al.
Publicado: (2020)

Adjuvant dendritic cell vaccination in high-risk uveal melanoma patients
por: Bol, Kalijn, et al.
Publicado: (2015)

The rationale for treating uveal melanoma with adjuvant melatonin: a review of the literature
por: Hagström, Anna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v8ea4k1s06f6a1e0g35eur9g3q